|
About the Get Involved category
|
|
0
|
36
|
August 22, 2024
|
|
My expierience with VIR-2218 and peg interferon
|
|
3
|
220
|
October 8, 2026
|
|
Joining the PBGENE-HBV (ELIMINATE-B) Phase 1 trial - anyone else? Thoughts on off-target / cancer risks?
|
|
11
|
776
|
September 19, 2026
|
|
Has anyone participated in clinical trials involving Brelovitug (BJT-778) or Bulevirtide?
|
|
0
|
116
|
September 17, 2026
|
|
FDA launches pilot program to speed up sluggish phase 1 trials
|
|
0
|
145
|
September 16, 2026
|
|
GSK B-United Study
|
|
61
|
3475
|
September 13, 2026
|
|
Urgent: Seeking HDV Treatment, Clinical Trial or Bulevirtide Access Options from Uzbekistan
|
|
8
|
227
|
September 4, 2026
|
|
Aligos Therapeutics Announces the Completion of Enrollment in the Phase 2 B-SUPREME Study of Pevifoscorvir Sodium Under Development for the Treatment of Chronic HBV Infection
|
|
2
|
284
|
August 3, 2026
|
|
World Hepatitis Day event: “Cure for Hepatitis B- hoax, hype, or hope?”
|
|
10
|
496
|
August 2, 2026
|
|
Free event: Hear about lived experiences from people in SE Asia/Oceania
|
|
1
|
84
|
August 2, 2026
|
|
Precision BioSciences Announces Initial Safety and Antiviral Activity
|
|
45
|
2537
|
August 2, 2026
|
|
Green Minds survey
|
|
2
|
166
|
July 18, 2026
|
|
2026 NYC Marathon
|
|
7
|
292
|
July 10, 2026
|
|
Hep B Lived Experience speakers are needed (Metropolitan Sydney, Australia)
|
|
0
|
105
|
July 2, 2026
|
|
Looking for recommendations: Strictly online consults with specialists in HBV functional cures (Bepirovirsen / ASOs)
|
|
3
|
240
|
June 22, 2026
|
|
Hep B Quality of Life Survey
|
|
0
|
108
|
June 17, 2026
|
|
Https://ir.ionis.com/news-releases/news-release-details/ionis-partner-gsk-announces-bepirovirsen-accepted-priority
|
|
1
|
210
|
June 10, 2026
|
|
China approves first-in-class monoclonal antibody for chronic hepatitis D treatment for
|
|
3
|
366
|
April 6, 2026
|
|
Hep B Writing Competition now open to everyone in NSW, Australia
|
|
13
|
281
|
February 16, 2026
|
|
Lived experience of US funding cuts - please share your story!
|
|
3
|
239
|
February 14, 2026
|
|
Confidential online program
|
|
0
|
141
|
February 7, 2026
|
|
The 16th Australasian Viral Hepatitis Conference - 12-14 August 2026
|
|
2
|
170
|
February 6, 2026
|
|
GSK announces positive data from phase 3 trials and plans to file regulatory approval in the first quarter of 2026
|
|
20
|
1829
|
January 28, 2026
|
|
Ausperbio announces AHB-137 Monotherapy achieves 30% functional cure in HBe-negative CHB patients on stable NA therapy
|
|
10
|
722
|
January 9, 2026
|
|
Upcoming ACIP Meeting: Public Comments
|
|
42
|
587
|
January 2, 2026
|
|
AusperBio Completes Patient Enrollment in Phase III AUSHINE Study of AHB-137 for Chronic Hepatitis B
|
|
0
|
189
|
December 23, 2025
|
|
Job opportunities in Australia - Hep B
|
|
1
|
161
|
December 18, 2025
|
|
Liver Tumor Article
|
|
10
|
629
|
December 9, 2025
|
|
Powerful new DNA editing method raises hopes for cures
|
|
0
|
198
|
December 4, 2025
|
|
An RNA interference therapeutic potentially achieves functional cure of chronic hepatitis B virus infection
|
|
2
|
282
|
December 2, 2025
|